| SC 13G/A | 2021-02-16 | D. E. SHAW & CO, L.P. | CymaBay Therapeutics, Inc. | 1,260,749 | 1.8% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | CymaBay Therapeutics, Inc. | 3,427,011 | 5.0% | EDGAR |
| SC 13G/A | 2021-01-29 | BlackRock Inc. | CymaBay Therapeutics, Inc. | 5,386,244 | 7.8% | EDGAR |
| SC 13G | 2020-09-24 | Boxer Capital, LLC | CymaBay Therapeutics, Inc. | 4,000,000 | 5.8% | EDGAR |
| SC 13G | 2020-09-01 | Avoro Capital Advisors LLC | CymaBay Therapeutics, Inc. | 10,300,000 | 15.0% | EDGAR |
| SC 13G | 2020-06-05 | D. E. SHAW & CO, L.P. | CymaBay Therapeutics, Inc. | 3,449,612 | 5.0% | EDGAR |
| SC 13D/A | 2020-05-13 | ENGINE CAPITAL, L.P. | CymaBay Therapeutics, Inc. | 1,731,606 | 2.5% | EDGAR |
| SC 13D/A | 2020-03-13 | ENGINE CAPITAL, L.P. | CymaBay Therapeutics, Inc. | 5,309,251 | 7.7% | EDGAR |
| SC 13D/A | 2020-02-14 | ENGINE CAPITAL, L.P. | CymaBay Therapeutics, Inc. | 5,501,130 | 8.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Point72 Asset Management, L.P. | CymaBay Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Newtyn Management, LLC | CymaBay Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Foresite Capital Fund III, L.P. | CymaBay Therapeutics, Inc. | 1,504,710 | 2.2% | EDGAR |
| SC 13G/A | 2020-02-14 | CITADEL ADVISORS LLC | CymaBay Therapeutics, Inc. | - | 3.5% | EDGAR |
| SC 13G/A | 2020-02-14 | BAKER BROS. ADVISORS LP | CymaBay Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-14 | PERCEPTIVE ADVISORS LLC | CymaBay Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2020-02-14 | Avoro Capital Advisors LLC | CymaBay Therapeutics, Inc. | 5,500,000 | 8.0% | EDGAR |
| SC 13G | 2020-02-11 | VANGUARD GROUP INC | CymaBay Therapeutics, Inc. | 3,691,325 | 5.4% | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | CymaBay Therapeutics, Inc. | 5,589,851 | 8.1% | EDGAR |
| SC 13G/A | 2020-01-23 | INTEGRATED CORE STRATEGIES (US) LLC | CymaBay Therapeutics, Inc. | 1,723,630 | 2.5% | EDGAR |
| SC 13G | 2019-12-20 | CITADEL ADVISORS LLC | CymaBay Therapeutics, Inc. | - | 3.5% | EDGAR |